We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.7B
1-Year Est. Return 173.77%
This Fund
S&P 500
This Quarter Est. Return
-8.68%
1 Year Est. Return
+173.77%
3 Year Est. Return
+266.65%
5 Year Est. Return
+530.55%
10 Year Est. Return
+2,805.24%
AUM
$429M
AUM Growth
-$85.5M
Cap. Flow
-$122M
Cap. Flow %
-28.48%
Top 10 Hldgs %
56.93%
Holding
56
New
3
Increased
8
Reduced
7
Closed
8

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$10.1M
2
IBB icon
iShares Biotechnology ETF
IBB
+$5.33M
3
NXST icon
Nexstar Media Group
NXST
+$3.08M
4
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$2.82M
5
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
+$2.13M

Top Sells

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$9.98M
2
ILMN icon
Illumina
ILMN
+$9.07M
3
EEFT icon
Euronet Worldwide
EEFT
+$8.81M
4
BABA icon
Alibaba
BABA
+$5.53M
5
XLRN
Acceleron Pharma
XLRN
+$5.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.71%
2 Healthcare 11.61%
3 Communication Services 10.58%
4 Consumer Discretionary 6.48%
5 Financials 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
META icon
26
Meta Platforms (Facebook)
META
$1.72T
$2.77M 0.65%
16,617
– –
WDC icon
27
CALL
Western Digital
WDC
$150B
$2.5M 0.58%
+79,380
New +$3.52M
CALM icon
28
Cal-Maine
CALM
$3.47B
$2.36M 0.55%
53,613
– –
DHT icon
29
DHT Holdings
DHT
$3.71B
$1.88M 0.44%
245,211
-190,585
-44% -$1.21M
PRVL
30
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$1.63M 0.38%
+133,690
New +$2.13M
NIO icon
31
CALL
NIO
NIO
$8.97B
$1.47M 0.34%
+530,000
New +$1.97M
WFC icon
32
Wells Fargo
WFC
$263B
$1.47M 0.34%
51,231
– –
SCU
33
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$1.1M 0.26%
81,068
– –
ACAD icon
34
Acadia Pharmaceuticals
ACAD
$4.75B
$829K 0.19%
19,613
– –
GOGO icon
35
PUT
Gogo Inc
GOGO
$346M
$636K 0.15%
300,000
– –
BMRN icon
36
BioMarin Pharmaceuticals
BMRN
$12.5B
$374K 0.09%
4,429
– –
SRPT icon
37
Sarepta Therapeutics
SRPT
$2.09B
$305K 0.07%
3,117
– –
WDC icon
38
Western Digital
WDC
$150B
$254K 0.06%
8,086
-12,436
-61% -$551K
ICPT
39
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$237K 0.06%
3,763
– –
BLUE
40
DELISTED
bluebird bio
BLUE
– –
-269
Closed -$306K
EEFT icon
41
Euronet Worldwide
EEFT
$2.58B
– –
-66,508
Closed -$8.81M
GDS icon
42
GDS Holdings
GDS
$6.09B
– –
-95,451
Closed -$4.92M
HPK icon
43
HighPeak Energy
HPK
$995M
– –
-500,000
Closed -$5.18M
ILMN icon
44
Illumina
ILMN
$34.6B
– –
-32,431
Closed -$9.07M
PTEN icon
45
Patterson-UTI
PTEN
$4.59B
– –
-91,114
Closed -$957K
SY
46
So-Young International
SY
$283M
– –
-87,500
Closed -$1.07M
PACQW
47
DELISTED
Pure Acquisition Corp. Warrant
PACQW
– –
-250,000
Closed -$246K
1
2

Similar funds

AHT
Amanah Holdings Trust London $1.7B AUM 612.53% 1-Year Est. Return
ARAM
Ardmore Road Asset Management New York $1.7B AUM 50.85% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.7B AUM 16.09% 1-Year Est. Return
TWP
Triad Wealth Partners Lawrence, Kansas $1.7B AUM 21.07% 1-Year Est. Return
FBB
Fulton Breakefield Broenniman Bethesda, Maryland $1.7B AUM 23.97% 1-Year Est. Return
GD
Galaxy Digital New York $1.7B AUM
SG
Sienna Gestion Paris, France $1.71B AUM 43.66% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.71B AUM 0.89% 1-Year Est. Return

QVT Financial's Q1 2020 Portfolio in Review

As of Q1 2020, QVT Financial held 56 positions worth $429M, down 17% from $514M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

QVT Financial withdrew a net $122M in Q1 2020, closing 8 positions and reducing 7 holdings. Its most notable exit was Illumina, an estimated $9.07M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 49% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, QVT Financial opened a new position in Prevail Therapeutics Inc. Common Stock worth $1.63M.

  • QVT Financial's largest Q1 2020 buy was Prevail Therapeutics Inc. Common Stock: 133,690 shares worth $1.63M.
  • QVT Financial added most to Goldman Sachs in Q1 2020, an estimated $10.1M increase.
  • QVT Financial's biggest Q1 2020 reduction was Iovance Biotherapeutics, cutting an estimated $9.98M.
  • QVT Financial fully exited Illumina in Q1 2020, selling an estimated $9.07M.
  • QVT Financial's ten largest holdings make up 57% of its $429M portfolio in Q1 2020.
  • QVT Financial opened 3 new positions and closed 8 in Q1 2020.
  • QVT Financial's portfolio value fell 17% quarter-over-quarter to $429M.

Based on QVT Financial's 13F filing for Q1 2020, filed 15 May 2020.